Previous 10 | Next 10 |
Rebounding from the Complete Response Letter (CRL) it received in June 2018, scPharmaceuticals (NASDAQ: SCPH ) has resubmitted its U.S. marketing application seeking approval of Furoscix (subcutaneous furosemide) for the treatment of congestion in heart failure patients. More news...
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that it has resubmitted its 505(b)(2) Ne...
The following slide deck was published by scPharmaceuticals Inc. in conjunction with this Read more ...
Quick Take scPharmaceuticals ( SCPH ) has taken two drugs that are generically available and very widely utilized in IV form and has reformulated them allowing for a more convenient subcutaneous route of administration. The innovation the company is offering is that the reformulated drugs ...
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced a new presentation time for BMO’s...
Shares of scPharmaceuticals (NASDAQ: SCPH) have plunged today, down by 22% as of 1 p.m. EDT, after the company announced the pricing of a public secondary offering. The deal priced at $8.65 per share, a roughly 20% discount compared to yesterday's closing price of $10.83. The pharmace...
Gainers: Surface Oncology (NASDAQ: SURF ) +82% . More news on: Surface Oncology, Inc., Nabors Industries Ltd., LMP Automotive Holdings, Inc., Stocks on the move, , Read more ...
scPharmaceuticals (NASDAQ: SCPH ) has priced its public offering of 5,780,347 common shares at $8.65, for gross proceeds of ~$50M. More news on: scPharmaceuticals Inc., Healthcare stocks news, , Read more ...
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced the pricing of an underwritten public of...
Gainers: ACB +26.4% . SCVL +5.8% . PGNX +4.4% . EVLO +3.4% . OPRA +3.4% . More news on: Aurora Cannabis Inc., Shoe Carnival, Inc., Progenics Pharmaceuticals, Inc., Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
scPharmaceuticals Inc. Company Name:
SCPH Stock Symbol:
NASDAQ Market:
scPharmaceuticals Inc. Website:
BURLINGTON, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today an...
A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 208.7% to $0.1698 on volume of 325,435,783 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 76.7% to $0.5039 on volume of 314,353,673 shares Greenwave Technology Solutions Inc. (GWAV) ros...
Generated 1Q 2024 net FUROSCIX ® revenue of $6.1 million, despite an estimated 10% impact to doses filled resulting from the Change Healthcare cyberattack Ended 1Q 2024 with cash and cash equivalents o f $58.4 million Company to host investor conference call and web...